Monarsen (EN101) is an antisense oligonucleotide that targets acetylcholinesterase (AChE) mRNA, specifically the “readthrough” isoform (AChE-R), and is under investigation as a symptomatic treatment for MG. Here, ACHE is linked to myasthenia gravis.